FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053649039> ?p ?o ?g. }

• W2053649039 endingPage "1114" @default.
• W2053649039 startingPage "1102" @default.
• W2053649039 abstract "In the present study, we prepared NGR-modified sterically stabilized liposomes containing paclitaxel (NGR-SSL-PTX) in order to evaluate their potential targeting to aminopeptidase N receptors expressed on tumor endothelial cells and the tumor cell surface and its anti-angiogenic activity following metronomic administration. NGR-SSL-PTX was prepared by a thin-film hydration method. The in vitro targeting characteristics of NGR-modified liposomes on HUVEC (human umbilical vein endothelial cells), HT1080 (human fibrosarcoma cells) and MCF-7 (human breast adenocarcinoma cells) were then investigated. The effect of NGR-SSL-PTX on HUVEC proliferation and migration was also tested. The pharmacokinetics of NGR-SSL-PTX was studied in rats. The in vivo targeting activity of NGR-modified liposomes was investigated in HT1080 tumor-bearing mice. The anti-tumor activity of NGR-SSL-PTX following metronomic administration was evaluated in HT1080 tumor-bearing mice in vivo. The targeting activity of the NGR-modified liposomes was demonstrated by in vitro flow cytometry and confocal microscopy as well as in vivo confocal immunofluorescence microscopy and bio-distribution experiments. The results of endothelial cell proliferation and migration and microvessel density (MVD) confirmed the anti-angiogenic activity of NGR-SSL-PTX in vitro and in vivo. The sustained circulation of NGR-SSL-PTX was shown in the pharmacokinetic study. NGR-SSL-PTX is able to improve treatment efficacy producing the most significant anti-tumor activity and anti-angiogenic following metronomic administration." @default.
• W2053649039 created "2016-06-24" @default.
• W2053649039 creator A5000824479 @default.
• W2053649039 creator A5008908578 @default.
• W2053649039 creator A5016622484 @default.
• W2053649039 creator A5028396164 @default.
• W2053649039 creator A5036093909 @default.
• W2053649039 creator A5038994209 @default.
• W2053649039 creator A5039837606 @default.
• W2053649039 creator A5049575988 @default.
• W2053649039 creator A5055543806 @default.
• W2053649039 creator A5061958596 @default.
• W2053649039 creator A5067534896 @default.
• W2053649039 date "2013-01-01" @default.
• W2053649039 modified "2023-10-16" @default.
• W2053649039 title "Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel" @default.
• W2053649039 cites W1967600348 @default.
• W2053649039 cites W1969313893 @default.
• W2053649039 cites W1969402650 @default.
• W2053649039 cites W1971822071 @default.
• W2053649039 cites W1980429250 @default.
• W2053649039 cites W1983195208 @default.
• W2053649039 cites W1984697909 @default.
• W2053649039 cites W1988313934 @default.
• W2053649039 cites W1990455420 @default.
• W2053649039 cites W1992891316 @default.
• W2053649039 cites W2001625103 @default.
• W2053649039 cites W2003474213 @default.
• W2053649039 cites W2007861578 @default.
• W2053649039 cites W2013470095 @default.
• W2053649039 cites W2025036947 @default.
• W2053649039 cites W2026404934 @default.
• W2053649039 cites W2027542963 @default.
• W2053649039 cites W2030646983 @default.
• W2053649039 cites W2030689193 @default.
• W2053649039 cites W2031630601 @default.
• W2053649039 cites W2033030572 @default.
• W2053649039 cites W2034449951 @default.
• W2053649039 cites W2039138706 @default.
• W2053649039 cites W2056637878 @default.
• W2053649039 cites W2059294866 @default.
• W2053649039 cites W2063284417 @default.
• W2053649039 cites W2078786745 @default.
• W2053649039 cites W2090806526 @default.
• W2053649039 cites W2094219250 @default.
• W2053649039 cites W2112973557 @default.
• W2053649039 cites W2117798942 @default.
• W2053649039 cites W2128090828 @default.
• W2053649039 cites W2130349349 @default.
• W2053649039 cites W2132257982 @default.
• W2053649039 cites W2132497528 @default.
• W2053649039 cites W2140088548 @default.
• W2053649039 cites W2154854806 @default.
• W2053649039 cites W2167107456 @default.
• W2053649039 cites W2169965478 @default.
• W2053649039 doi "https://doi.org/10.1016/j.biomaterials.2012.10.029" @default.
• W2053649039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23127332" @default.
• W2053649039 hasPublicationYear "2013" @default.
• W2053649039 type Work @default.
• W2053649039 sameAs 2053649039 @default.
• W2053649039 citedByCount "92" @default.
• W2053649039 countsByYear W20536490392013 @default.
• W2053649039 countsByYear W20536490392014 @default.
• W2053649039 countsByYear W20536490392015 @default.
• W2053649039 countsByYear W20536490392016 @default.
• W2053649039 countsByYear W20536490392017 @default.
• W2053649039 countsByYear W20536490392018 @default.
• W2053649039 countsByYear W20536490392019 @default.
• W2053649039 countsByYear W20536490392020 @default.
• W2053649039 countsByYear W20536490392021 @default.
• W2053649039 countsByYear W20536490392022 @default.
• W2053649039 countsByYear W20536490392023 @default.
• W2053649039 crossrefType "journal-article" @default.
• W2053649039 hasAuthorship W2053649039A5000824479 @default.
• W2053649039 hasAuthorship W2053649039A5008908578 @default.
• W2053649039 hasAuthorship W2053649039A5016622484 @default.
• W2053649039 hasAuthorship W2053649039A5028396164 @default.
• W2053649039 hasAuthorship W2053649039A5036093909 @default.
• W2053649039 hasAuthorship W2053649039A5038994209 @default.
• W2053649039 hasAuthorship W2053649039A5039837606 @default.
• W2053649039 hasAuthorship W2053649039A5049575988 @default.
• W2053649039 hasAuthorship W2053649039A5055543806 @default.
• W2053649039 hasAuthorship W2053649039A5061958596 @default.
• W2053649039 hasAuthorship W2053649039A5067534896 @default.
• W2053649039 hasConcept C121608353 @default.
• W2053649039 hasConcept C126322002 @default.
• W2053649039 hasConcept C150903083 @default.
• W2053649039 hasConcept C171250308 @default.
• W2053649039 hasConcept C185154212 @default.
• W2053649039 hasConcept C185592680 @default.
• W2053649039 hasConcept C192562407 @default.
• W2053649039 hasConcept C202751555 @default.
• W2053649039 hasConcept C203014093 @default.
• W2053649039 hasConcept C207001950 @default.
• W2053649039 hasConcept C2777292972 @default.
• W2053649039 hasConcept C2777411675 @default.
• W2053649039 hasConcept C2777751087 @default.
• W2053649039 hasConcept C2777834122 @default.

• next